Feizhou Huang
- Molecular Biology
- Cancer Research top 5%
- Epidemiology top 10%
- Immunology
- Surgery
- Topics
- Cancer-related molecular mechanisms research (12 papers)MicroRNA in disease regulation (8 papers)Circular RNAs in diseases (6 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Feizhou Huang
27 papers receiving 965 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 587
- Cancer Research 471
- Epidemiology 258
- Immunology 174
- Surgery 88
Countries citing papers authored by Feizhou Huang
This map shows the geographic impact of Feizhou Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feizhou Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feizhou Huang more than expected).
Fields of papers citing papers by Feizhou Huang
This network shows the impact of papers produced by Feizhou Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feizhou Huang. The network helps show where Feizhou Huang may publish in the future.
Co-authorship network of co-authors of Feizhou Huang
This figure shows the co-authorship network connecting the top 25 collaborators of Feizhou Huang. A scholar is included among the top collaborators of Feizhou Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feizhou Huang. Feizhou Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 16 | |
| 3 | 13 | |
| 4 | 21 | |
| 5 | 66 | |
| 6 | 62 | |
| 7 | 147 | |
| 8 | 28 | |
| 9 | 71 | |
| 10 | 0 | |
| 11 | 12 | |
| 12 | 90 | |
| 13 | 47 | |
| 14 | MiR-15b mediates liver cancer cells proliferation through targeting BCL-2. | 40 |
| 15 | 113 | |
| 16 | 3 | |
| 17 | 8 | |
| 18 | 8 | |
| 19 | 47 | |
| 20 | 8 |
About Feizhou Huang
Feizhou Huang is a scholar working on Cancer Research, Electrochemistry and Molecular Biology, having authored 28 papers that have together received 978 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (6 papers). The work is most often cited by research in Cancer Research (471 citations), Hepatology (81 citations) and Molecular Biology (587 citations). Feizhou Huang has collaborated with scholars based in China and United States. Frequent co-authors include Hongwu Luo, Chuanzheng Sun, Mingshi Yang, Zhongjie Yi, Huaizheng Liu, Yang Liu, Xuefei Xiao, Gui Hu, Lei Zhao and Patricia Loughran. Their work appears in journals such as Hepatology, Biochemical and Biophysical Research Communications and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.